These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30428508)

  • 1. von Willebrand Factor Antigen Predicts Outcomes in Patients after Liver Resection of Hepatocellular Carcinoma.
    Schwarz C; Fitschek F; Mittlböck M; Saukel V; Bota S; Ferlitsch M; Ferlitsch A; Bodingbauer M; Kaczirek K
    Gut Liver; 2020 Mar; 14(2):218-224. PubMed ID: 30428508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bivalent property of intra-platelet VWF in liver regeneration and HCC recurrence: A prospective multicenter study.
    Aryal B; Yamakuchi M; Shimizu T; Kadono J; Furoi A; Gejima K; Takenouchi K; Komokata T; Hashiguchi T; Imoto Y
    Cancer Biomark; 2019; 26(1):51-61. PubMed ID: 31322547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative von Willebrand factor dynamics are associated with liver regeneration and predict outcome after liver resection.
    Starlinger P; Pereyra D; Haegele S; Braeuer P; Oehlberger L; Primavesi F; Kohler A; Offensperger F; Reiberger T; Ferlitsch A; Messner B; Beldi G; Staettner S; Brostjan C; Gruenberger T
    Hepatology; 2018 Apr; 67(4):1516-1530. PubMed ID: 29140542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
    Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
    BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal-invasive versus open hepatectomy for hepatocellular carcinoma: Comparison of postoperative outcomes and long-term survivals using propensity score matching analysis.
    Andreou A; Struecker B; Raschzok N; Krenzien F; Haber P; Wabitsch S; Waldbaur C; Touet EM; Eichelberg AC; Atanasov G; Biebl M; Bahra M; Öllinger R; Schmelzle M; Pratschke J
    Surg Oncol; 2018 Dec; 27(4):751-758. PubMed ID: 30449503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is liver resection for hepatocellular carcinoma in cirrhotic patients with high preoperative serum alanine aminotransferase level unadvisable?
    Lai CY; Wu CC; Wang J; Yu CC; Cheng SB; Yeh DC; Peng FK
    Hepatogastroenterology; 2014 Oct; 61(135):2068-76. PubMed ID: 25713912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Child-Pugh grade
    Huang F; Gao J
    World J Gastroenterol; 2020 Feb; 26(7):749-758. PubMed ID: 32116422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma.
    Maegawa FB; Shehorn L; Aziz H; Kettelle J; Jie T; Riall TS
    JAMA Netw Open; 2019 Jan; 2(1):e187142. PubMed ID: 30657533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.
    Györi GP; Pereyra D; Rumpf B; Hackl H; Köditz C; Ortmayr G; Reiberger T; Trauner M; Berlakovich GA; Starlinger P
    Hepatology; 2020 Aug; 72(2):584-594. PubMed ID: 31773739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of surgical complications and preoperative serum hepatocyte growth factor in hepatocellular carcinoma patients after initial hepatectomy.
    Mizuguchi T; Nagayama M; Meguro M; Shibata T; Kaji S; Nobuoka T; Kimura Y; Furuhata T; Hirata K
    J Gastrointest Surg; 2009 Feb; 13(2):325-33. PubMed ID: 18846405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating von Willebrand factor antigen as a predictor of short-term prognosis in pulmonary hypertension.
    Lopes AA; Maeda NY
    Chest; 1998 Nov; 114(5):1276-82. PubMed ID: 9824001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
    Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
    J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-glutamyl transpeptidase to platelet ratio predicts short-term outcomes in hepatocellular carcinoma patients undergoing minor liver resection.
    Ke MY; Zhang M; Su Q; Wei S; Zhang J; Wang Y; Wu R; Lv Y
    J Surg Res; 2018 Nov; 231():403-410. PubMed ID: 30278960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
    Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
    World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A
    Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of preoperative von Willebrand factor plasma levels in patients with Glioblastoma.
    Marfia G; Navone SE; Fanizzi C; Tabano S; Pesenti C; Abdel Hadi L; Franzini A; Caroli M; Miozzo M; Riboni L; Rampini P; Campanella R
    Cancer Med; 2016 Aug; 5(8):1783-90. PubMed ID: 27236861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated preoperative serum CA19-9 levels in patients with hepatocellular carcinoma is associated with poor prognosis after resection.
    Chen YL; Chen CH; Hu RH; Ho MC; Jeng YM
    ScientificWorldJournal; 2013; 2013():380797. PubMed ID: 23843733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.